Paul Saultier, MD, PhD (@psaultier) header
Paul Saultier, MD, PhD (@psaultier) profile picture
Marseille, France
Joined July 2017
Photo by Paul Saultier, MD, PhD (@psaultier)Photo by Paul Saultier, MD, PhD (@psaultier)Photo by Paul Saultier, MD, PhD (@psaultier)Photo by Paul Saultier, MD, PhD (@psaultier)Photo by Paul Saultier, MD, PhD (@psaultier)Photo by Paul Saultier, MD, PhD (@psaultier)Photo by Paul Saultier, MD, PhD (@psaultier)Photo by Paul Saultier, MD, PhD (@psaultier)Photo by Paul Saultier, MD, PhD (@psaultier)Photo by Paul Saultier, MD, PhD (@psaultier)
Le @CRPP12 et l'@AFH_Officiel organisent le 1er weekend d'éducation thérapeutique du patient 100% pathologies plaquettaires! 📍Strasbourg 📅19 et 20 novembre 2022. Pour vous inscrire: fr.surveymonkey.com/r/WEPPST… Plus d'infos: maladies-plaquettes.org/even… et afh.asso.fr/2022/09/28/parti…
1
2
1
Paul Saultier, MD, PhD retweeted
Our study is finally published in @jclinicalinvest! Anti-leukemic activity in the absence of severe toxicities with nonviral Sleeping Beauty–engineered CAR T cells. Thanks to all our great collaborators. #Immunotherapy #tcells #GeneTherapy jci.org/articles/view/138473
Paul Saultier, MD, PhD retweeted
Novel mechanism of FLT3 activation in BCP-ALL
13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking ow.ly/7FKx50B8JPG
1
2
Paul Saultier, MD, PhD retweeted
(Examines patient with conjunctivitis) Brain: Touch your face Me: What...no...why Brain: it itches Me: No it doesn’t, stop Brain: IT ITCHES Me: please I beg you Brain: IT ITC̸͈̯̩͍͍̞̞̙̭̖̰̊͋̂̋̋̓̀̾̔̀̚Ȟ̶̨̛̻̳͉̪͙̯̹̗̘͜E̷͙̞͓̱͙͈̓̓̔̊̆̓̆ͅS̴̛͖̯͉͇̳̠͈̘̠̈́͐͘͝ͅ
11
90
9
999
Paul Saultier, MD, PhD retweeted
Pour les cancers de l’enfants ce traitement par CAR-T-Cells est proposé à l’aphm @aphm_actu dans le service d’oncologie de l’hôpital d’enfants timone. Un des rares services français leader en onco pédiatrie a avoir cette autorisation
[Repost] Une très belle avancée cette année : @paoli_calmettes de #Marseille propose un nouveau traitement pour guérir les cancers du sang ! Une véritable révolution 👏 #Santé
1
16
27
Paul Saultier, MD, PhD retweeted
Replying to @psaultier
@psaultier presenting high-level evidence for APA benefits in children with cancer @aphm_actu @SIOPYI_Network #SIOP2019
3
4
Paul Saultier, MD, PhD retweeted
#SIOP2019 Durin: SPINK1 genetic polymorphism maybe a risk factor for ASP associated panreatitis in French kids with ALL
2
1
Paul Saultier, MD, PhD retweeted
Great presentation on patient centered approach in respiratory distress management by F. Craig #SIOP2019
2
2
Paul Saultier, MD, PhD retweeted
Replying to @psaultier
@psaultier thanks for following I have been teaching photography to cancer affected children past several years as part of my Mission helping them battle disease through creativity My video about my work youtu.be/qN4wf3HZxYI
1
3
Traitement de la #thalassémie : un article très complet pour comprendre les enjeux, les progrès et espoirs liés aux essais cliniques en cours👉 fr.ap-hm.fr/actu/therapie-ge… #ThérapieGénique #greffe #recherche
Paul Saultier, MD, PhD retweeted
Original Article: Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency nej.md/2k1FbZ4

7
2
15
I spoke with Medscape about EINSTEIN-Jr presentation at #ISTH2019: Rivaroxaban Safe, Effective in Kids With #VTE. It will be great to see the full publication on this landmark trial medscape.com/viewarticle/915… via @medscape
1
13
Paul Saultier, MD, PhD retweeted
ISTH just keeps getting better - Manuela Albisetti presents data on dabigatran for upfront therapy of pediatric VTE #ISTH2019 #NCHkids
7
17
Paul Saultier, MD, PhD retweeted
“You raise me up to walk on stormy seas I am strong when I am on your shoulders You raise me up to more than I can be” #SIOP2018 #childhoodcancerawareness #pediatriconcology
8
1
26
Paul Saultier, MD, PhD retweeted
About a third of r/r AML can be targeted with CD7 CAR T cells, without the risk of myeloablation. Clinical study planned Q2 2019 at Baylor cell.com/molecular-therapy-f…
4
17
2
31
Paul Saultier, MD, PhD retweeted
Mohamad Mohty delivering the last presentation at the special CAR-T Cell session at IACH. There is a large unmet educational need to train all categories of healthcare personnel involved in the administration and evaluation of immune effector cells.
Paul Saultier, MD, PhD retweeted
If you care for patients with #Glanzmann #Thrombasthenia this review on management of those with anti-IIb/IIIa antibodies is outstanding. An uncommon but serious situation. Keep a copy handy, plus one in the medical notes of all affected patients? https://xitter.gq/t.co/2sGNe4mQI4
1
8
2
26
Paul Saultier, MD, PhD retweeted
A deadly childhood brain cancer has long been thought to spread through fluid in the brain. But new findings show that the tumour cells can travel through the blood #ResearchHighlight go.nature.com/2F03Gyb